251 related articles for article (PubMed ID: 16997128)
21. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
Cho H; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):461-5. PubMed ID: 12468268
[TBL] [Abstract][Full Text] [Related]
22. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
[TBL] [Abstract][Full Text] [Related]
23. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.
Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ
Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
25. Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.
Liu Z; Wang X; Lu Y; Han S; Zhang F; Zhai H; Lei T; Liang J; Wang J; Wu K; Fan D
Carcinogenesis; 2008 Jun; 29(6):1219-27. PubMed ID: 18174234
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
[TBL] [Abstract][Full Text] [Related]
27. Expression of prostaglandin metabolising enzymes COX-2 and 15-PGDH and VDR in human granulosa cells.
Thill M; Becker S; Fischer D; Cordes T; Hornemann A; Diedrich K; Salehin D; Friedrich M
Anticancer Res; 2009 Sep; 29(9):3611-8. PubMed ID: 19667156
[TBL] [Abstract][Full Text] [Related]
28. Indomethacin and telomerase activity in tumor growth retardation.
Lönnroth C; Andersson M; Lundholm K
Int J Oncol; 2001 May; 18(5):929-37. PubMed ID: 11295037
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
Backlund MG; Mann JR; Dubois RN
Oncology; 2005; 69 Suppl 1():28-32. PubMed ID: 16210874
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
Dial EJ; Doyen JR; Lichtenberger LM
Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
[TBL] [Abstract][Full Text] [Related]
31. Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase.
Quidville V; Segond N; Pidoux E; Cohen R; Jullienne A; Lausson S
Endocrinology; 2004 May; 145(5):2561-71. PubMed ID: 14736730
[TBL] [Abstract][Full Text] [Related]
32. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
Nystrom ML; McCulloch D; Weinreb PH; Violette SM; Speight PM; Marshall JF; Hart IR; Thomas GJ
Cancer Res; 2006 Nov; 66(22):10833-42. PubMed ID: 17108119
[TBL] [Abstract][Full Text] [Related]
34. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
Stoner GD; Qin H; Chen T; Carlton PS; Rose ME; Aziz RM; Dixit R
Carcinogenesis; 2005 Sep; 26(9):1590-5. PubMed ID: 15878914
[TBL] [Abstract][Full Text] [Related]
35. In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I.
Ottanà R; Carotti S; Maccari R; Landini I; Chiricosta G; Caciagli B; Vigorita MG; Mini E
Bioorg Med Chem Lett; 2005 Sep; 15(17):3930-3. PubMed ID: 15993594
[TBL] [Abstract][Full Text] [Related]
36. Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells.
Chan MW; Wong CY; Cheng AS; Chan VY; Chan KK; To KF; Chan FK; Sung JJ; Leung WK
Oncol Rep; 2007 Dec; 18(6):1557-62. PubMed ID: 17982644
[TBL] [Abstract][Full Text] [Related]
37. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
Moreno J; Krishnan AV; Peehl DM; Feldman D
Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
[TBL] [Abstract][Full Text] [Related]
39. Biosynthesis and catabolism of prostaglandin F2alpha (PGF2alpha) are controlled by progesterone in the rat uterus during pregnancy.
Farina M; Ribeiro ML; Weissmann C; Estevez A; Billi S; Vercelli C; Franchi A
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):211-8. PubMed ID: 15336698
[TBL] [Abstract][Full Text] [Related]
40. Effects of non-steroidal anti-inflammatory drugs on cell proliferation and death in cultured epiphyseal-articular chondrocytes of fetal rats.
Chang JK; Wu SC; Wang GJ; Cho MH; Ho ML
Toxicology; 2006 Dec; 228(2-3):111-23. PubMed ID: 17045721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
